A new Yale study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.
The study is based on Phase 3 clinical trials using baricitinib, a Janus kinase (JAK) inhibitor, to treat alopecia areata, an often disfiguring skin disease characterized by rapid loss of scalp hair, and sometimes eyebrows and eyelashes.
“This is so exciting, because …
Positive News Foundation is a certified non-profit sharing only the best positive world news.
All copyrights belong to the source.
No copyright infringement is intended.
Email support@positivenewsfoundation.org to fix/remove.
GET POSITIVE NEWS PER E-MAIL
ONLY BEST POSITIVE NEWS
FROM LAST WEEK
FOR FREE IN YOUR E-MAIL INBOX
ONLY 1X PER WEEK
PNF is a Dutch certified nonprofit sharing international positive world news. We share today's good news, success stories and inspirational happy news articles in English.
KvK nr 85046248 - RSIN nr 863486137Sign up for our FREE weekly newspaper The Sunday Paper to receive this week's good news in your inbox - every Sunday >>© 2021 Positive News Foundation or its affiliated organizations. All rights reserved.
